New
Fda Approves First Rapid-acting Insulin Biosimilar For Patients With Diabetes
The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus.
Popular Products
-
Sevich Chebe Hair Loss Treatment Set$73.99$50.78 -
Super Fenugreek & Rosemary Hair Regro...$117.99$81.78 -
Sevich Hair Keratin & Moroccan Oil Vi...$34.99$23.78 -
Sevich African Chebe Hair Treatment Set$73.99$50.78 -
Sevich Hair Growth Essence Spray$28.99$19.78